Cargando…
Case Report: Complete response after tislelizumab treatment in a hepatocellular carcinoma patient with abdominal lymph node metastasis
BACKGROUND: Abdominal lymph node (ALN) metastasis is associated with a poor prognosis in patients with hepatocellular carcinoma (HCC) because of the limited number of effective therapeutic options available. Immunotherapy with immune checkpoint inhibitors, such as those targeting programmed death re...
Autores principales: | Deng, Haihui, Chen, Bin, Peng, Deti, He, Jian, Zhao, Weicheng, Chen, Tuantuan, Xie, Zonggui, Pang, Fuwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166873/ https://www.ncbi.nlm.nih.gov/pubmed/37180122 http://dx.doi.org/10.3389/fimmu.2023.1163656 |
Ejemplares similares
-
Pathological complete response to neoadjuvant tislelizumab plus chemotherapy in stage IIIB small cell lung cancer: A case report and literature review
por: Zhou, Nan, et al.
Publicado: (2023) -
Case Report: Clinical Responses to Tislelizumab as a First-Line Therapy for Primary Hepatocellular Carcinoma With B-Cell Indolent Lymphoma
por: Li, Qijun, et al.
Publicado: (2021) -
Tislelizumab for cervical cancer: A retrospective study and analysis of correlative blood biomarkers
por: Zheng, Xiaojing, et al.
Publicado: (2023) -
Abdominal Schwannoma Mimicking Lymph Node Metastasis in Rectal Cancer
por: Kotrri, Enxhi, et al.
Publicado: (2022) -
Case Report: Successful Management of a Refractory Plasmablastic Lymphoma Patient With Tislelizumab and Lenalidomide
por: Cheng, Lili, et al.
Publicado: (2021)